{
    "2021-08-31": [
        [
            {
                "time": "",
                "original_text": "葛兰、赵蓓、郑磊等医药基金二季度隐形重仓公司",
                "features": {
                    "keywords": [
                        "葛兰",
                        "赵蓓",
                        "郑磊",
                        "医药基金",
                        "隐形重仓",
                        "二季度"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗(300003)：业绩略超预期 期待创新器械发力",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "业绩",
                        "超预期",
                        "创新器械"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "和讯SGI公司|之江生物SGI最新得分84 公司上半年净利润降9.59%，集采致产品毛利下降 盈利能力下降",
                "features": {
                    "keywords": [
                        "和讯SGI",
                        "江生物",
                        "净利润下降",
                        "集采",
                        "毛利下降",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "萧楠等基金“顶流”隐形重仓股浮出水面",
                "features": {
                    "keywords": [
                        "萧楠",
                        "基金",
                        "顶流",
                        "隐形重仓股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "12年营收翻了20倍，董事长年薪却从193万元跌到0元",
                "features": {
                    "keywords": [
                        "营收增长",
                        "董事长年薪",
                        "下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}